Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report
25 avr. 2024 14h00 HE
|
Progyny
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for...
Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
17 avr. 2024 09h23 HE
|
Progyny
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and Fertility Matters Canada, a national...
Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast
04 avr. 2024 08h59 HE
|
Progyny
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and RESOLVE: The National Infertility...
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
18 mars 2024 12h00 HE
|
Progyny
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski,...
Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference
11 mars 2024 12h00 HE
|
Progyny
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski,...
Progyny, Inc. Announces Share Repurchase Program
29 févr. 2024 07h30 HE
|
Progyny
NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, announced today that its Board of...
Progyny, Inc. Announces Fourth Quarter 2023 Results
27 févr. 2024 16h01 HE
|
Progyny
Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion...
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2023 Results Report
13 févr. 2024 16h30 HE
|
Progyny
NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the...
Progyny Expands its Leadership Team
11 janv. 2024 09h01 HE
|
Progyny
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced two newly created roles with...
Progyny, Inc. to Present at 42nd Annual J.P. Morgan Healthcare Conference
08 janv. 2024 10h30 HE
|
Progyny
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s...